Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

29 Apr 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral Infections and Immunology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32353252
DOI: 10.1016/j.cell.2020.04.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaPMID 32353252Read ↗

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 InfectionSemantic proximity Read ↗

Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in HumansSemantic proximity Read ↗

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas SystemsSemantic proximity Read ↗

Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host InteractionsSemantic proximity Read ↗

CRISPR-Cas based targeting of host and viral genes as an antiviral strategySemantic proximity Read ↗

CRISPR-Cas: a game-changer in vaccine development and the fight against viral infectionsSemantic proximity Read ↗

A CRISPR toolbox to study virus–host interactionsSemantic proximity Read ↗

CRISPR/Cas technology as a promising weapon to combat viral infectionsSemantic proximity Read ↗

The Impact of CRISPR-Cas System on Antiviral TherapySemantic proximity Read ↗

A short overview of CRISPR-Cas technology and its application in viral disease controlSemantic proximity Read ↗

Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applicationsSemantic proximity Read ↗

CRISPR Screening: Molecular Tools for Studying Virus–Host InteractionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.